findmyKOL

Gad Silberman, MD

Basic profile

ATP Clinical Research

ORCIDNone on fileNPI
RegionTallahassee, FL · SoutheastSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Gad Silberman is a Cardiology physician affiliated with ATP Clinical Research. OpenAlex indexes 5 publications with 274 citations (h-index 2).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
5publications

Distinct works indexed by OpenAlex.

274citations

Total citations across indexed works.

2h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
24companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2100 Centerville Rd
Tallahassee, FL 323084379

Telephone

850-216-0178

Provider last certified this registry record 6 May 2024.

View the NPPES registry record

Industry payments

24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    54.8%
    Beta blocker27.5%
    Metoprolol Succinate76%Carvedilol14%Sotalol6%Atenolol1%Metoprolol Tartrate1%Nadolol1%Propranolol Hcl Er1%
    Part D<11 patients
    Calcium channel blocker8.9%
    Amlodipine Besylate35%Diltiazem 24hr Er (Cd)34%Dilt-Xr8%Diltiazem 24hr Er6%Diltiazem 12hr Er5%Nifedipine Er3%Diltiazem Hcl3%Tiadylt Er3%Diltiazem 24hr Er (Xr)2%Verapamil Er1%
    Part D<11 patients

    + 13 more classes in this area

  • Blood & clotting

    41.1%
    Factor Xa inhibitor38.8%
    Eliquis91%Xarelto9%
    Part D564 patients
    Direct thrombin inhibitors1.2%
    Dabigatran Etexilate100%
    Part D62 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    3.1%
    SGLT2 inhibitor2%
    Jardiance100%
    Part D42 patients
    Potassium supplement1.2%
    Potassium Chloride100%
    Part D34 patients
Where care is delivered (Part B)27.4% facility · 72.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”